Search

everythinglearnresearchcommunity

for

Search:↓

Combining PRP with hydroquinone is more effective for treating melasma than using hydroquinone alone.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Ivermectin 1% cream effectively reduces visible and invisible symptoms of rosacea.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Higher uric acid levels are linked to fewer urinary symptoms in healthy Korean men.

Women with PCOS experience more psychological symptoms and need emotional support.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Vaccinated healthcare workers rarely experience long COVID-19 symptoms.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Ashwagandha is safe and effective for reducing perimenopausal symptoms.

Certain immune responses may cause ongoing COVID-19 symptoms like fatigue and brain fog.

The scalp serum reduced scalp discomfort and symptoms without affecting skin moisture loss.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Severe hair loss may worsen with skin condition, suggesting treating the skin might help.

Severe hair loss may increase the risk of dying from COVID-19.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

The TT/DHT ratio may help identify PCOS patients with severe metabolic issues.

Auriculotherapy and Aslagh capsules are as effective as metformin for treating PCOS symptoms, with auriculotherapy slightly better for reducing hair growth.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Hair manganese may relate to cardiometabolic health, not coronary artery disease severity.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Chinese women's hair gets thinner and grayer with age, and scalp conditions change, especially after 40.